The absence of a Marvel film to kick off the summer movie season in 2024 is a significant departure from recent years. For more than a decade, Marvel Cinematic Universe films have dominated the summer box office, consistently generating massive openings of over $100 million. However, this year, the mantle was picked up by Universal’s
Business
Oddity Tech, the Israeli cosmetics platform utilizing artificial intelligence, has defied expectations with its first-quarter results. The company reported earnings per share of 61 cents adjusted, surpassing the anticipated 49 cents. Additionally, their revenue of $211.63 million exceeded the expected $205 million. This impressive performance resulted in a net income of $32.98 million, or 53
Former Starbucks CEO Howard Schultz has recently commented on the company’s disappointing quarterly report, expressing his belief that Starbucks can bounce back by enhancing its U.S. stores. Schultz, though no longer holding a formal role within the organization, pinpointed a crucial factor contributing to the decline. He emphasized the necessity for Starbucks to improve its
Amgen’s stock saw a significant increase of more than 12% after providing positive initial data on its new weight loss injection, MariTide. This announcement fueled concerns among investors regarding the potential new competition in the rapidly expanding weight loss drug market. As a result, the shares of the current major players in the obesity drug
Wayfair announced a decline in sales during its first quarter, reporting a reduction in losses following a 13% cut in its workforce earlier in the year. The online furniture retailer managed to surpass Wall Street’s expectations in terms of both revenue and losses, with active customer numbers growing by nearly 3% compared to the previous
Johnson & Johnson recently announced a $6.5 billion settlement to resolve the thousands of lawsuits in the U.S. claiming that their talc-based products caused ovarian cancer. This settlement, spanning over 25 years, aims to put an end to the financial and public relations troubles that J&J has faced due to these legal battles. The company
Recently, a federal judge in New Jersey made a significant ruling regarding Johnson & Johnson’s and Bristol Myers Squibb’s legal challenges to the Biden administration’s Medicare drug-price negotiations. The judge rejected their claims, stating that the program is constitutional. This decision marks a victory for the White House in its ongoing legal dispute with multiple
Paramount Global is on the verge of making a major change at the top executive level, as Chief Executive Officer Bob Bakish is expected to be replaced with a group of existing division heads. The decision, set to be announced on Monday, is seen as a strategic move to accelerate the company’s future endeavors. The
The Food and Drug Administration recently approved Pfizer’s gene therapy treatment for hemophilia B, marking a significant milestone for the company. This groundbreaking approval opens up new possibilities for patients suffering from this rare genetic bleeding disorder. However, as we delve deeper into the details of this approval, it is crucial to critically analyze the
Walgreens is taking a significant step by working directly with drugmakers to bring cell and gene therapies to U.S. patients. This move is part of a broader expansion of its specialty pharmacy services. The company is venturing into a new business unit dedicated to its specialty pharmacy segment, which includes the specialty pharmacy subsidiary AllianceRx.